We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

13:00 Tecsys Inc. élargit sa portée mondiale avec l'adoption par Roche d'Elite ? pour la gestion des stocks de laboratoire CI ...

European shares bounced back on Wednesday following four sessions of declines on optimism around positive developments in the Ukraine-Russia conflict, while a cooler-than-expected U.S. inflation ...

This advertisement has not loaded yet, but your article continues below. SUMMERSIDE, P.E.I. — Mixed doubles curling is providing an opportunity for two household names in Canada to continue their ...